Search results
Trial data support non-antibiotic treatment for bacterial vaginosis
Center for Infectious Disease Research and Policy· 3 days agoThe trial investigated the efficacy of the broad-spectrum antiseptic dequalinium chloride for...
Women Need Better Treatments for Bacterial Vaginosis
Newswise· 6 days agoBALTIMORE, May 2, 2024: Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased ...
Women need better treatments for bacterial vaginosis: Researchers call for studies for a treatment...
Medical Xpress· 4 days agoDQC—an antiseptic—has been in use for several decades in countries throughout Europe as an alternative treatment for BV. It is not currently approved by the U.S. Food and ...
Daré Bioscience, Inc. (NASDAQ:DARE) Sees Significant Growth in Short Interest
ETF DAILY NEWS· 4 days agoDaré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 246,900 shares, a growth ...
How to prevent the 8 most common women's intimate health mistakes
Yahoo Life UK· 5 days agoWith waiting lists for gynaecological treatment long, here's what you can do to help prevent less...
Autism Spectrum Disorder (ASD)
Health via Yahoo News· 4 days agoAutism spectrum disorder (ASD) is a neurodevelopmental condition that causes brain differences that can affect your emotions, behavior, and social...
Vaginal thrush: What's up 'down there'?
dpa international via Yahoo News· 3 days agoWith symptoms that include itching and burning, vaginal thrush is no fun. Many women are understandably reluctant to talk about it, although medical...
Prebys Foundation Announces $7 Million "Prebys Research Heroes" Program to Improve Medical Research...
Newswise· 7 days agoSAN DIEGO, April 30, 2024 /PRNewswire/ -- The Prebys Foundation has launched a $7 million program designed to bring more diverse perspectives into the laboratory and yield ground-breaking medical ...
Needham & Company LLC Reiterates Buy Rating for Hologic (NASDAQ:HOLX)
ETF DAILY NEWS· 2 days agoHologic (NASDAQ:HOLX – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a research note issued to investors on Friday, Benzinga reports. Needham & Company LLC ...